IRIS
SPAGNUOLO, ROCCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.121
EU - Europa 992
AS - Asia 588
SA - Sud America 71
OC - Oceania 40
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.068
IT - Italia 407
SG - Singapore 379
DE - Germania 193
GB - Regno Unito 115
FI - Finlandia 97
BR - Brasile 60
CN - Cina 57
SE - Svezia 48
CA - Canada 41
NL - Olanda 38
AU - Australia 32
IN - India 29
KH - Cambogia 18
IR - Iran 17
FR - Francia 14
RO - Romania 13
MY - Malesia 12
TH - Thailandia 10
HK - Hong Kong 9
MX - Messico 8
NZ - Nuova Zelanda 8
PL - Polonia 8
RU - Federazione Russa 8
ES - Italia 7
AT - Austria 6
ET - Etiopia 6
ID - Indonesia 6
JP - Giappone 6
LV - Lettonia 6
CO - Colombia 5
CZ - Repubblica Ceca 5
SA - Arabia Saudita 5
YE - Yemen 5
GR - Grecia 4
IE - Irlanda 4
PK - Pakistan 4
TW - Taiwan 4
VN - Vietnam 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
CY - Cipro 3
DK - Danimarca 3
KR - Corea 3
PH - Filippine 3
RS - Serbia 3
TR - Turchia 3
UA - Ucraina 3
CH - Svizzera 2
CU - Cuba 2
EC - Ecuador 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
MK - Macedonia 2
NO - Norvegia 2
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
HU - Ungheria 1
IQ - Iraq 1
KW - Kuwait 1
LC - Santa Lucia 1
LT - Lituania 1
MA - Marocco 1
PE - Perù 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.826
Salva come PNG Salva come JPEG
Città #
Singapore 207
Chandler 191
Munich 151
Santa Clara 86
Milan 83
Chicago 59
Helsinki 58
London 55
Lawrence 50
Princeton 50
Catanzaro 47
Ashburn 38
Turku 31
Boardman 30
Rome 26
Council Bluffs 23
Wilmington 23
Edinburgh 22
Phnom Penh 18
Des Moines 16
Redwood City 11
Sydney 11
Los Angeles 10
Palermo 10
Redmond 10
Hamilton 9
Toronto 9
Christchurch 8
New York 8
San Nicola Manfredi 8
São Paulo 8
Adelaide 7
Amsterdam 7
Brooklyn 7
Florence 7
Hanover 7
Mexico City 7
Shanghai 7
Brisbane 6
Fortaleza 6
Norwalk 6
Pattaya 6
Perth 6
Riga 6
San Francisco 6
Taranto 6
Bari 5
Beijing 5
Boston 5
Buffalo 5
Campo Bom 5
Catania 5
Collegeville 5
Delhi 5
Guangzhou 5
Hong Kong 5
Horia 5
Jyväskylä 5
Nuremberg 5
Olomouc 5
Ottawa 5
Provo 5
Sanaa 5
Seattle 5
Turin 5
Verona 5
Washington 5
Assago 4
Athens 4
Berlin 4
Bolzano 4
Campinas 4
Castellammare di Stabia 4
Chennai 4
Cittanova 4
Falkenstein 4
Gdynia 4
Hortolândia 4
Hyderabad 4
Johor Bahru 4
Kuching 4
Leeds 4
Montreal 4
Naples 4
Santiago de Cali 4
The Dalles 4
Tokyo 4
Warsaw 4
Aversa 3
Bangkok 3
Bengaluru 3
Castrovillari 3
Charlotte 3
Decatur 3
Jiaxing 3
Kahramanmaraş 3
Ouro Fino 3
Plymouth 3
Riverside 3
Riyadh 3
Totale 1.688
Salva come PNG Salva come JPEG
Nome #
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 276
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 210
BETA-GLUCAN, INOSITOL AND DIGESTIVE ENZYMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH IRRITABLE BOWEL SYNDROME 200
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 80
L’epatopatia alcolica: dal danno alla terapia 55
Anti interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report. 54
Patient Reported Outcomes come strumento infermieristico nella gestione delle Malattie Infiammatorie Croniche Intestinali (MICI): Sintomi Gastrointestinali e Alterazioni Psicosociali. 53
The role of gluten-free diet in nonalcoholic fatty liver disease development 53
Acceptability of endoscopic procedures and patients' willingness to repeat them: a single-centre nursing study of influential factors 52
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 50
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 46
Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge 46
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 45
COMPARISON BETWEEN DIFFERENT BOWEL PREPARATION REGIMENS FOR COLONOSCOPY: A SINGLE-CENTRE STUDY 44
DIAPHRAGMATIC REHABILITATION IN GASTROOESOPHAGEAL REFLUX DISEASE 43
OUTCOME OF ARTHRALGIA IN A SUBGROUP OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTI-TNF-ALPHA. A SINGLE CENTRE STUDY 42
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 40
Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia 40
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 38
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 38
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 37
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 37
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 36
C-reactive protein induces tissue factor expression and promotes smooth muscle cells and endothelial cell proliferation 36
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 36
Nursing communication as a tool for patient satisfaction. A single hospital survey 34
Psychometric evaluation of an Italian custom 4-item short form of the PROMIS anxiety item bank in immune-mediated inflammatory diseases: An item response theory analysis 34
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 33
Nursing issues in enteral nutrition during prone position in critically ill patients: A systematic review of the literature 33
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. 32
HIGH DIAGNOSTIC YIELD OF HISTOLOGICAL ANALYSIS OF EUS FINE-NEEDLE ASPIRATION BIOPSY INCLUDED IN FORMALIN WITHOUT ON-SITE CYTOPATHOLOGIC EXAMINATION. A RETROSPECTIVE STUDY 31
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 31
Pro-atherothrombotic effects of sigarette smoking in endothelial cells. Protective effects of statins 30
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 30
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 30
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 28
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 27
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 26
Effect of excess body weight on the genetic susceptibility to cancer. 26
Surgery for a gastric Dieulafoy's lesion reveals an occult bleeding jejunal diverticulum. A case report. 26
Milk Thistle, Silybum marianum 26
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 26
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 26
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 26
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 25
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review 25
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 25
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 24
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 24
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 24
Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease 24
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 23
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 22
Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: A nursing-led cross-sectional study of patients in clinical remission 21
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 20
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 20
Cross talk between liver and adipose tissue: A new role for PNPLA3? 20
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 20
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 19
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 19
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 19
W1173 An In Vivo Study to Evaluate {MLCK} Expression in Patients with Inflammatory Bowel Diseases 18
Esophageal rupture after Heimlich maneuver: a case report and literature review 17
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 17
Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review 17
The role of Neopterin in cardiovascular disease 17
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. 17
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases 17
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 16
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 16
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 14
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 14
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 14
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 14
Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 14
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 13
Milk thistle, Sylibum marianum 12
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 11
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 11
MBOAT7 in liver and extrahepatic diseases 11
Impact of Nursing Interventions via Telephone and Email on the Quality of Life of Patients with Inflammatory Bowel Disease: Preliminary Results of a Comparative Observational Study 10
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 10
Visualization of Comorbidities in Inflammatory Bowel Diseases through Networks 10
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 10
Lived Experiences of Patients With Inflammatory Bowel Disease in Italy: A Phenomenological Investigation 8
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies 7
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 7
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 6
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 6
OBSERVING THE INFLUENCE OF SHAME AND GUILT IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW 3
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study 3
Totale 2.976
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 8 6 7 28 47 17 17 13 41 5 4 13
2021/2022208 7 1 6 41 16 8 9 39 15 35 22 9
2022/2023672 104 52 23 64 56 47 19 73 86 47 64 37
2023/2024552 94 68 49 32 41 94 25 44 22 14 15 54
2024/20251.288 139 41 39 44 94 148 127 77 158 41 144 236
2025/20261 1 0 0 0 0 0 0 0 0 0 0 0
Totale 2.976